SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-090373
Filing Date
2023-11-28
Accepted
2023-11-28 08:05:27
Documents
14
Period of Report
2023-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189077-8k_bimiinter.htm   iXBRL 8-K 34098
2 FORM OF WARRANT PURCHASE AGREEMENTS ea189077ex4-1_bimiinter.htm EX-4.1 46769
3 PRESS RELEASE DATED NOVEMBER 28, 2023 ea189077ex99-1_bimiinter.htm EX-99.1 4140
  Complete submission text file 0001213900-23-090373.txt   275225

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bimi-20231127.xsd EX-101.SCH 3009
5 XBRL LABEL FILE bimi-20231127_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bimi-20231127_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea189077-8k_bimiinter_htm.xml XML 3411
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 231441936
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries